Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» HeartWare stock gains 4.5% as analysts predict FDA approval ahead of panel meeting
HeartWare stock gains 4.5% as analysts predict FDA approval ahead of panel meeting
HeartWare stock gains 4.5% as analysts predict FDA approval ahead of panel meeting
Submitted by
moderatorj
on April 23, 2012 - 10:58pm
Source:
Mass Device
News Tags:
HeartWare
stock
FDA
Headline:
HeartWare stock gains 4.5% as analysts predict FDA approval ahead of panel meeting
Do Not Allow Advertisers to Use My Personal information
